Characteristics of the 160 patients
| Variable . | No. (%) . |
|---|---|
| Patient-specific | |
| Male sex | 113 (70.6) |
| Median age, y (range) | 56 (32-65) |
| Stage IV | 136 (85.0) |
| Splenomegaly | 72 (45.0) |
| Extranodal disease other than BM | 51 (31.9) |
| International Prognostic Index (IPI) | |
| 0-1 | 35 (21.9) |
| 2 | 69 (43.1) |
| 3 | 42 (26.3) |
| 4-5 | 14 (8.8) |
| Disease-specific | |
| Cytologic variant | |
| Blastoid/pleomorphic | 31 (19.4) |
| Common | 129 (80.6) |
| Growth pattern (assessed in 151) | |
| Nodular | 26 (17.2) |
| Mantle | 5 (3.3) |
| Mixed | 39 (25.8) |
| Diffuse | 81 (53.6) |
| Ki-67 expression (assessed in 120) | |
| 0-9 | 10 (8.3) |
| 10-29 | 60 (50.0) |
| > 29 | 50 (41.7) |
| Variable . | No. (%) . |
|---|---|
| Patient-specific | |
| Male sex | 113 (70.6) |
| Median age, y (range) | 56 (32-65) |
| Stage IV | 136 (85.0) |
| Splenomegaly | 72 (45.0) |
| Extranodal disease other than BM | 51 (31.9) |
| International Prognostic Index (IPI) | |
| 0-1 | 35 (21.9) |
| 2 | 69 (43.1) |
| 3 | 42 (26.3) |
| 4-5 | 14 (8.8) |
| Disease-specific | |
| Cytologic variant | |
| Blastoid/pleomorphic | 31 (19.4) |
| Common | 129 (80.6) |
| Growth pattern (assessed in 151) | |
| Nodular | 26 (17.2) |
| Mantle | 5 (3.3) |
| Mixed | 39 (25.8) |
| Diffuse | 81 (53.6) |
| Ki-67 expression (assessed in 120) | |
| 0-9 | 10 (8.3) |
| 10-29 | 60 (50.0) |
| > 29 | 50 (41.7) |